Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.890
+0.100 (3.58%)
At close: Feb 5, 2026

Clarity Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
1,0758041,689182132-
Market Cap Growth
-17.46%-52.42%825.73%38.70%--
Enterprise Value
9916921,65110735-
Last Close Price
2.892.505.420.700.51-
PS Ratio
113.6284.93146.7918.6220.37-
PB Ratio
11.928.9111.552.641.43-
P/TBV Ratio
11.928.9111.552.641.43-
EV/Sales Ratio
104.7373.18143.4910.875.40-
Asset Turnover
0.070.070.100.110.110.20
Quick Ratio
9.089.0818.449.9513.199.91
Current Ratio
9.699.6919.0510.1713.2610.00
Return on Equity (ROE)
-54.37%-54.37%-39.28%-30.48%-42.23%-71.89%
Return on Assets (ROA)
-33.76%-33.76%-23.87%-18.65%-17.41%-40.63%
Return on Capital Employed (ROCE)
-76.10%-76.10%-30.20%-38.00%-18.50%-50.60%
Earnings Yield
-5.98%-8.00%-2.51%-13.48%-18.06%-
FCF Yield
-5.11%-6.84%-2.59%-15.10%-10.28%-
Buyback Yield / Dilution
-16.86%-16.86%-5.22%-4.81%-40.37%-20.54%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.